State,Registrant Name,Client Name,Filing Type,Amount Reported,Date Posted,Filing Year
DE,Alcalde & Fay,ASTRAZENECA,YEAR-END REPORT,"$40,000.00 ",2/14/2000,1999
DE,Alcalde & Fay,ASTRAZENECA,YEAR-END TERMINATION,"$20,000.00 ",2/14/2001,2000
DE,Alcalde & Fay,ASTRAZENECA,MID-YEAR REPORT,"$20,000.00 ",8/14/2000,2000
DE,Alcalde & Fay,ASTRAZENECA,MID-YEAR REPORT,"$40,000.00 ",8/16/1999,1999
DE,Alcalde & Fay,ASTRAZENECA,REGISTRATION AMENDMENT,,8/16/1999,1999
DE,"ALPINE GROUP, INC.",DUPONT PHARMACEUTICAL CO,YEAR-END REPORT,"$40,000.00 ",2/5/2001,2000
DE,"ALPINE GROUP, INC.",DUPONT PHARMACEUTICAL CO,YEAR-END REPORT,"$40,000.00 ",2/9/2002,2001
DE,"ALPINE GROUP, INC.",DUPONT PHARMACEUTICAL CO,YEAR-END REPORT,"$40,000.00 ",2/15/2000,1999
DE,"ALPINE GROUP, INC.",DUPONT PHARMACEUTICAL CO,MID-YEAR TERMINATION,"$40,000.00 ",3/26/2002,2002
DE,"ALPINE GROUP, INC.",DUPONT PHARMACEUTICAL CO,MID-YEAR REPORT,"$40,000.00 ",8/3/2000,2000
DE,"ALPINE GROUP, INC.",DUPONT PHARMACEUTICAL CO,MID-YEAR REPORT,"$40,000.00 ",8/6/1999,1999
DE,"ALPINE GROUP, INC.",DUPONT PHARMACEUTICAL CO,MID-YEAR TERMINATION,,8/9/2002,2002
DE,ALSTON & BIRD LLP,Noramco,FOURTH QUARTER REPORT,"$50,000.00 ",1/21/2020,2019
DE,ALSTON & BIRD LLP,Noramco,REGISTRATION,,11/20/2019,2019
DE,"ARC STRATEGIC SOLUTIONS, INC",AMERICAN ASSN OF PHYSICIAN SPECIALISTS,REGISTRATION,,3/26/2003,2003
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$620,000.00 ",1/19/2018,2017
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$810,000.00 ",1/19/2019,2018
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$1,220,000.00 ",1/20/2010,2009
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$660,000.00 ",1/20/2011,2010
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$460,000.00 ",1/20/2015,2014
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$487,808.00 ",1/20/2016,2015
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$464,210.00 ",1/20/2017,2016
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$1,090,000.00 ",1/21/2009,2008
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$520,000.00 ",1/21/2012,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$520,000.00 ",1/21/2012,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$650,000.00 ",1/21/2014,2013
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$510,000.00 ",1/21/2020,2019
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER REPORT,"$340,000.00 ",1/22/2013,2012
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,YEAR-END REPORT,"$320,000.00 ",2/13/2001,2000
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER AMENDMENT,"$1,140,000.00 ",2/13/2009,2008
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,REGISTRATION,,2/14/2000,2000
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,YEAR-END REPORT,"$1,240,000.00 ",2/14/2006,2005
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,YEAR-END REPORT,"$1,380,000.00 ",2/14/2007,2006
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,YEAR-END REPORT,"$1,700,000.00 ",2/14/2008,2007
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER AMENDMENT,"$900,000.00 ",2/18/2013,2012
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER AMENDMENT,"$510,000.00 ",2/20/2012,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER AMENDMENT,"$1,420,000.00 ",2/20/2012,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,YEAR-END REPORT,"$640,000.00 ",2/25/2003,2002
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER AMENDMENT,"$650,000.00 ",3/26/2014,2013
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$700,000.00 ",4/19/2017,2017
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$600,000.00 ",4/19/2018,2018
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$1,250,000.00 ",4/20/2009,2009
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$1,700,000.00 ",4/20/2010,2010
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$1,330,000.00 ",4/20/2011,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$1,180,000.00 ",4/20/2012,2012
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$503,000.00 ",4/20/2015,2015
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$1,080,000.00 ",4/20/2016,2016
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$770,000.00 ",4/21/2008,2008
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$1,030,000.00 ",4/21/2014,2014
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$1,210,000.00 ",4/22/2013,2013
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER REPORT,"$1,060,000.00 ",4/22/2019,2019
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,YEAR-END REPORT,"$520,000.00 ",4/24/2002,2001
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER AMENDMENT,"$560,000.00 ",5/2/2014,2013
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER AMENDMENT,"$620,000.00 ",5/2/2019,2018
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER AMENDMENT,"$660,000.00 ",5/8/2012,2010
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER AMENDMENT,"$770,000.00 ",5/28/2008,2008
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER AMENDMENT,"$520,000.00 ",6/10/2015,2014
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER AMENDMENT,"$1,190,000.00 ",6/18/2012,2012
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$438,391.00 ",7/19/2016,2016
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$730,000.00 ",7/19/2017,2017
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$480,000.00 ",7/19/2019,2019
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$1,240,000.00 ",7/20/2009,2009
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$740,000.00 ",7/20/2010,2010
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$680,000.00 ",7/20/2011,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$360,000.00 ",7/20/2012,2012
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$460,000.00 ",7/20/2018,2018
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$1,340,000.00 ",7/21/2008,2008
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$480,000.00 ",7/21/2014,2014
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER AMENDMENT,"$1,200,000.00 ",7/22/2009,2009
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$460,000.00 ",7/22/2013,2013
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER AMENDMENT,"$480,000.00 ",7/22/2014,2014
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER REPORT,"$1,080,000.00 ",7/30/2015,2015
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER AMENDMENT,"$1,350,000.00 ",8/10/2011,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,MID-YEAR REPORT,"$320,000.00 ",8/11/2000,2000
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,MID-YEAR REPORT,"$1,460,000.00 ",8/14/2006,2006
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,MID-YEAR REPORT,"$2,380,000.00 ",8/14/2007,2007
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FIRST QUARTER AMENDMENT,"$1,110,000.00 ",8/16/2012,2012
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER AMENDMENT,"$520,000.00 ",8/19/2014,2014
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,MID-YEAR REPORT,"$520,000.00 ",8/20/2002,2002
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER AMENDMENT,"$680,000.00 ",8/20/2013,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,MID-YEAR REPORT,"$680,000.00 ",8/21/2003,2003
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER AMENDMENT,"$740,000.00 ",8/23/2010,2010
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER AMENDMENT,"$680,000.00 ",8/31/2011,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER AMENDMENT,"$860,000.00 ",9/3/2019,2019
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,FOURTH QUARTER AMENDMENT,"$810,000.00 ",9/27/2019,2018
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$450,000.00 ",10/18/2019,2019
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$1,410,000.00 ",10/19/2011,2011
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$856,379.00 ",10/19/2016,2016
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$339,000.00 ",10/19/2017,2017
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$510,000.00 ",10/19/2018,2018
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$1,320,000.00 ",10/20/2008,2008
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$1,200,000.00 ",10/20/2009,2009
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$1,460,000.00 ",10/20/2010,2010
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$880,000.00 ",10/20/2014,2014
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER AMENDMENT,"$450,000.00 ",10/20/2019,2019
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$970,000.00 ",10/21/2013,2013
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$977,925.00 ",10/21/2015,2015
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,THIRD QUARTER REPORT,"$980,000.00 ",10/22/2012,2012
DE,AstraZeneca Pharmaceuticals LP,ASTRAZENECA PHARMACEUTICALS LP,SECOND QUARTER AMENDMENT,"$370,000.00 ",10/29/2012,2012
DE,Baker & Hostetler LLP,ASTRAZENECA PHARMACEUTICALS LP,YEAR-END REPORT,"$60,000.00 ",2/12/2004,2003
DE,Baker & Hostetler LLP,ASTRAZENECA PHARMACEUTICALS LP,MID-YEAR TERMINATION,"$20,000.00 ",8/13/2004,2004
DE,Baker & Hostetler LLP,ASTRAZENECA PHARMACEUTICALS LP,REGISTRATION,,12/5/2003,2003
DE,"Becker & Poliakoff, P.A.",LifeVU LLC,REGISTRATION,,2/13/2020,2020
DE,Bingham McCutchen LLP,AstraZeneca Pharmaceuticals LP,REGISTRATION,,2/14/2007,2007
DE,"Buchanan Ingersoll & Rooney, PC","Amivas, LLC",REGISTRATION,,4/17/2019,2019
DE,"Buchanan Ingersoll & Rooney, PC","Amivas, LLC",SECOND QUARTER REPORT,"$20,000.00 ",7/22/2019,2019
DE,"Buchanan Ingersoll & Rooney, PC","Amivas, LLC",THIRD QUARTER REPORT,"$20,000.00 ",10/21/2019,2019
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",FOURTH QUARTER TERMINATION,"$30,000.00 ",1/19/2012,2011
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",FOURTH QUARTER REPORT,"$30,000.00 ",1/20/2010,2009
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",FOURTH QUARTER REPORT,"$30,000.00 ",1/20/2011,2010
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",FOURTH QUARTER REPORT,,1/21/2009,2008
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",REGISTRATION,,2/7/2007,2007
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",YEAR-END REPORT,"$120,000.00 ",2/8/2008,2007
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",FIRST QUARTER REPORT,"$30,000.00 ",4/18/2011,2011
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",FIRST QUARTER REPORT,"$30,000.00 ",4/20/2009,2009
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",FIRST QUARTER REPORT,"$30,000.00 ",4/20/2010,2010
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",FIRST QUARTER REPORT,"$60,000.00 ",4/21/2008,2008
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",SECOND QUARTER REPORT,"$30,000.00 ",7/16/2009,2009
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",SECOND QUARTER REPORT,"$30,000.00 ",7/19/2010,2010
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",SECOND QUARTER REPORT,"$30,000.00 ",7/20/2011,2011
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",SECOND QUARTER REPORT,"$120,000.00 ",7/21/2008,2008
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",MID-YEAR REPORT,"$120,000.00 ",8/24/2007,2007
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",THIRD QUARTER REPORT,"$30,000.00 ",10/14/2010,2010
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",THIRD QUARTER REPORT,"$120,000.00 ",10/17/2008,2008
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",THIRD QUARTER REPORT,"$30,000.00 ",10/18/2011,2011
DE,"Capitol Counsel, LLC","AstraZeneca Pharmaceuticals, LP",THIRD QUARTER REPORT,"$30,000.00 ",10/20/2009,2009
DE,"Cassidy & Associates, Inc.",CHRISTIANA CARE CORP,REGISTRATION,,1/24/2002,2002
DE,Cozen O'Connor Public Strategies,Association of Builders & Contractors Delaware Chapter,FOURTH QUARTER REPORT,"$10,000.00 ",1/17/2013,2012
DE,Cozen O'Connor Public Strategies,Association of Builders & Contractors Delaware Chapter,FOURTH QUARTER REPORT,"$10,000.00 ",1/17/2014,2013
DE,Cozen O'Connor Public Strategies,Association of Builders & Contractors Delaware Chapter,SECOND QUARTER REPORT,"$10,000.00 ",7/18/2012,2012
DE,Cozen O'Connor Public Strategies,Association of Builders & Contractors Delaware Chapter,THIRD QUARTER REPORT,"$10,000.00 ",10/8/2013,2013
DE,Cozen O'Connor Public Strategies,Association of Builders & Contractors Delaware Chapter,THIRD QUARTER REPORT,"$10,000.00 ",10/16/2012,2012
DE,Denny Miller Associates,DUPONT,MID-YEAR REPORT,"$60,000.00 ",8/4/2000,2000
DE,Dickstein Shapiro LLP,COMMUNITY HEALTH LEADERSHIP NETWORK,YEAR-END REPORT,,2/13/2004,2003
DE,Dickstein Shapiro LLP,COMMUNITY HEALTH LEADERSHIP NETWORK,REGISTRATION,,7/30/2003,2003
DE,Dickstein Shapiro LLP,COMMUNITY HEALTH LEADERSHIP NETWORK,MID-YEAR TERMINATION,,8/11/2004,2004
DE,Dickstein Shapiro LLP,COMMUNITY HEALTH LEADERSHIP NETWORK,MID-YEAR REPORT,,8/13/2003,2003
DE,"FAHMY HUDOME INTERNATIONAL, INC",Saliba Action Strategies (on behalf of Islamic Relief Worldwide),REGISTRATION,,5/18/2018,2018
DE,FOXKISER,ASTRAZENECA PHARMACEUTICALS LP,YEAR-END REPORT,"$20,000.00 ",3/19/2002,2001
DE,FOXKISER,ASTRAZENECA PHARMACEUTICALS LP,REGISTRATION,,8/1/2001,2001
DE,"Hannegan Landau Poersch & Rosenbaum Advocacy, LLC","Peachtree Health Group, LLC",FOURTH QUARTER REPORT,"$30,000.00 ",1/3/2020,2019
DE,"Hannegan Landau Poersch & Rosenbaum Advocacy, LLC","Peachtree Health Group, LLC",REGISTRATION,,3/29/2019,2019
DE,"Hannegan Landau Poersch & Rosenbaum Advocacy, LLC","Peachtree Health Group, LLC",FIRST QUARTER REPORT,"$10,000.00 ",4/14/2019,2019
DE,"Hannegan Landau Poersch & Rosenbaum Advocacy, LLC","Peachtree Health Group, LLC",SECOND QUARTER REPORT,"$30,000.00 ",7/22/2019,2019
DE,"Hannegan Landau Poersch & Rosenbaum Advocacy, LLC","Peachtree Health Group, LLC",THIRD QUARTER REPORT,"$30,000.00 ",10/21/2019,2019
DE,"Jones Walker, LLP",Noramco,FOURTH QUARTER REPORT,,1/21/2020,2019
DE,"Jones Walker, LLP",Noramco,REGISTRATION,,11/1/2019,2019
DE,"Mercury Public Affairs, LLC",Global Leadership Institute,REGISTRATION,,4/19/2013,2013
DE,Mr. Dan Perrin,Harmonious Code Council,REGISTRATION,,10/19/2016,2016
DE,MWW Group,Christiana Care Health System,FOURTH QUARTER REPORT,"$20,000.00 ",1/17/2014,2013
DE,MWW Group,Christiana Care Health System,FOURTH QUARTER REPORT,"$30,000.00 ",1/20/2011,2010
DE,MWW Group,Christiana Care Health System,SECOND QUARTER REPORT,"$10,000.00 ",7/15/2010,2010
DE,MWW Group,Christiana Care Health System,REGISTRATION,,10/15/2009,2009
DE,MWW Group,Christiana Care Health System,THIRD QUARTER REPORT,"$20,000.00 ",10/19/2010,2010
DE,MWW Group,Christiana Care Health System,THIRD QUARTER REPORT,"$20,000.00 ",10/20/2015,2015
DE,"Navigators Global LLC (Formerly DC Navigators, LLC)",Lockbay LLC,FOURTH QUARTER TERMINATION,"$50,000.00 ",1/21/2014,2013
DE,"Navigators Global LLC (Formerly DC Navigators, LLC)",Lockbay LLC,REGISTRATION,,7/11/2013,2013
DE,"Navigators Global LLC (Formerly DC Navigators, LLC)",Lockbay LLC,SECOND QUARTER REPORT,"$20,000.00 ",7/19/2013,2013
DE,"Navigators Global LLC (Formerly DC Navigators, LLC)",Lockbay LLC,THIRD QUARTER REPORT,"$50,000.00 ",10/21/2013,2013
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,FOURTH QUARTER REPORT,"$30,000.00 ",1/18/2015,2014
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,FOURTH QUARTER TERMINATION,"$30,000.00 ",1/19/2016,2015
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,REGISTRATION,,3/27/2014,2014
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$30,000.00 ",4/16/2014,2014
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$30,000.00 ",4/19/2015,2015
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$30,000.00 ",7/18/2014,2014
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$30,000.00 ",7/19/2015,2015
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$30,000.00 ",10/17/2014,2014
DE,Ogilvy Government Relations,AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$30,000.00 ",10/18/2015,2015
DE,Peck Madigan Jones,"Quantum Leap Innovations, Inc.",FOURTH QUARTER REPORT,"$20,000.00 ",1/20/2010,2009
DE,Peck Madigan Jones,"Quantum Leap Innovations, Inc.",FIRST QUARTER TERMINATION,"$30,000.00 ",4/20/2010,2010
DE,Peck Madigan Jones,"Quantum Leap Innovations, Inc.",REGISTRATION,,10/6/2009,2009
DE,Peck Madigan Jones,"Quantum Leap Innovations, Inc.",THIRD QUARTER AMENDMENT,"$20,000.00 ",10/22/2009,2009
DE,Peck Madigan Jones,"Secretary of State, State of Delaware",REGISTRATION,,5/8/2009,2009
DE,POLICY DIRECTIONS INC.,Water Hay Oats Alliance,FOURTH QUARTER TERMINATION,"$10,000.00 ",1/16/2014,2013
DE,POLICY DIRECTIONS INC.,Water Hay Oats Alliance,REGISTRATION,,11/14/2013,2013
DE,SPLITOAK STRATEGIES LLC,iPug US Inc.,REGISTRATION,,5/1/2018,2018
DE,SPLITOAK STRATEGIES LLC,iPug US Inc.,FIRST QUARTER REPORT,"$10,000.00 ",5/28/2018,2018
DE,SPLITOAK STRATEGIES LLC,iPug US Inc.,SECOND QUARTER REPORT,"$30,000.00 ",7/18/2018,2018
DE,SPLITOAK STRATEGIES LLC,iPug US Inc.,THIRD QUARTER TERMINATION,"$20,000.00 ",10/22/2018,2018
DE,STRATEGIC HEALTH SOLUTIONS,ASTRAZENECA PHARMACEUTICALS,YEAR-END TERMINATION,"$120,000.00 ",2/5/2007,2006
DE,STRATEGIC HEALTH SOLUTIONS,ASTRAZENECA PHARMACEUTICALS,YEAR-END REPORT,"$120,000.00 ",2/10/2006,2005
DE,STRATEGIC HEALTH SOLUTIONS,ASTRAZENECA PHARMACEUTICALS,REGISTRATION,,4/13/2005,2005
DE,STRATEGIC HEALTH SOLUTIONS,ASTRAZENECA PHARMACEUTICALS,YEAR-END REPORT,"$60,000.00 ",5/2/2005,2004
DE,STRATEGIC HEALTH SOLUTIONS,ASTRAZENECA PHARMACEUTICALS,MID-YEAR REPORT,"$120,000.00 ",7/26/2006,2006
DE,STRATEGIC HEALTH SOLUTIONS,ASTRAZENECA PHARMACEUTICALS,MID-YEAR REPORT,"$120,000.00 ",8/8/2005,2005
DE,SWIDLER BERLIN LLP,YM BIOSCIENCES USA,REGISTRATION,,1/6/2006,2005
DE,SWIDLER BERLIN LLP,YM BIOSCIENCES USA,YEAR-END REPORT,"$2,000.00 ",2/21/2006,2005
DE,SWIDLER BERLIN LLP,YM BIOSCIENCES USA,MID-YEAR TERMINATION,"$20,000.00 ",8/18/2006,2006
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,FOURTH QUARTER REPORT,"$40,000.00 ",1/19/2016,2015
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,FOURTH QUARTER REPORT,"$40,000.00 ",1/20/2015,2014
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$40,000.00 ",4/17/2015,2015
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$40,000.00 ",4/19/2016,2016
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$40,000.00 ",7/17/2015,2015
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$40,000.00 ",7/20/2016,2016
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,REGISTRATION,,7/21/2014,2014
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$40,000.00 ",7/22/2014,2014
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$40,000.00 ",10/19/2015,2015
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$40,000.00 ",10/19/2016,2016
DE,The Glover Park Group LLC,AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$40,000.00 ",10/20/2014,2014
DE,The Magnate Group LLC,IBIO INC (FORMELY KNOWN AS 'IBIOPHARMA INC ' - EFFECTIVE 1-1-2010),REGISTRATION,,7/13/2009,2009
DE,The McManus Group,AstraZeneca,FOURTH QUARTER REPORT,"$7,500.00 ",1/20/2015,2014
DE,The McManus Group,AstraZeneca,FOURTH QUARTER REPORT,"$7,500.00 ",1/21/2014,2013
DE,The McManus Group,AstraZeneca,FOURTH QUARTER AMENDMENT,"$7,500.00 ",2/12/2019,2013
DE,The McManus Group,AstraZeneca,FIRST QUARTER REPORT,"$10,000.00 ",4/20/2015,2015
DE,The McManus Group,AstraZeneca,FIRST QUARTER REPORT,"$7,500.00 ",4/21/2014,2014
DE,The McManus Group,AstraZeneca,SECOND QUARTER REPORT,"$7,500.00 ",7/17/2014,2014
DE,The McManus Group,AstraZeneca,SECOND QUARTER REPORT,"$10,000.00 ",7/20/2015,2015
DE,The McManus Group,AstraZeneca,THIRD QUARTER REPORT,"$7,500.00 ",10/20/2014,2014
DE,The McManus Group,AstraZeneca,REGISTRATION,,10/21/2013,2013
DE,The McManus Group,AstraZeneca,THIRD QUARTER REPORT,,10/23/2013,2013
DE,"Twenty-First Century Group, Inc.",NeuroRx,FOURTH QUARTER REPORT,"$30,000.00 ",1/21/2020,2019
DE,"Twenty-First Century Group, Inc.",NeuroRx,FOURTH QUARTER REPORT,"$30,000.00 ",1/22/2019,2018
DE,"Twenty-First Century Group, Inc.",NeuroRx,REGISTRATION,,1/24/2018,2017
DE,"Twenty-First Century Group, Inc.",NeuroRx,FOURTH QUARTER REPORT,"$5,000.00 ",1/31/2018,2017
DE,"Twenty-First Century Group, Inc.",NeuroRx,FIRST QUARTER REPORT,"$20,000.00 ",4/20/2018,2018
DE,"Twenty-First Century Group, Inc.",NeuroRx,FIRST QUARTER REPORT,"$30,000.00 ",4/22/2019,2019
DE,"Twenty-First Century Group, Inc.",NeuroRx,SECOND QUARTER REPORT,"$30,000.00 ",7/19/2019,2019
DE,"Twenty-First Century Group, Inc.",NeuroRx,SECOND QUARTER REPORT,"$20,000.00 ",7/20/2018,2018
DE,"Twenty-First Century Group, Inc.",NeuroRx,THIRD QUARTER REPORT,"$30,000.00 ",10/19/2018,2018
DE,"Twenty-First Century Group, Inc.",NeuroRx,THIRD QUARTER REPORT,"$30,000.00 ",10/21/2019,2019
DE,University of Delaware,University of Delaware,FIRST QUARTER REPORT,"$50,000.00 ",4/20/2012,2012
DE,University of Delaware,University of Delaware,SECOND QUARTER REPORT,"$30,000.00 ",7/20/2015,2015
DE,US Strategies,ADVOSERV,FOURTH QUARTER TERMINATION,"$20,000.00 ",1/4/2017,2016
DE,US Strategies,ADVOSERV,FOURTH QUARTER REPORT,"$30,000.00 ",1/8/2015,2014
DE,US Strategies,ADVOSERV,FOURTH QUARTER REPORT,"$10,000.00 ",1/15/2009,2008
DE,US Strategies,ADVOSERV,FOURTH QUARTER REPORT,"$10,000.00 ",1/17/2014,2013
DE,US Strategies,ADVOSERV,FOURTH QUARTER REPORT,"$50,000.00 ",1/18/2011,2010
DE,US Strategies,ADVOSERV,FOURTH QUARTER REPORT,"$40,000.00 ",1/18/2012,2011
DE,US Strategies,ADVOSERV,FOURTH QUARTER REPORT,"$40,000.00 ",1/18/2013,2012
DE,US Strategies,ADVOSERV,FOURTH QUARTER REPORT,"$10,000.00 ",1/19/2010,2009
DE,US Strategies,ADVOSERV,YEAR-END REPORT,,2/9/2000,1999
DE,US Strategies,ADVOSERV,YEAR-END REPORT,,2/11/2005,2004
DE,US Strategies,ADVOSERV,YEAR-END REPORT,,2/13/2001,2000
DE,US Strategies,ADVOSERV,YEAR-END REPORT,"$10,000.00 ",2/13/2008,2007
DE,US Strategies,ADVOSERV,YEAR-END REPORT,,2/14/2002,2001
DE,US Strategies,ADVOSERV,YEAR-END REPORT,"$40,000.00 ",2/20/2007,2006
DE,US Strategies,ADVOSERV,YEAR-END REPORT,,2/24/2003,2003
DE,US Strategies,ADVOSERV,YEAR-END REPORT,,2/25/2003,2002
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$10,000.00 ",4/12/2013,2013
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$30,000.00 ",4/15/2016,2016
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$10,000.00 ",4/17/2009,2009
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$30,000.00 ",4/17/2014,2014
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$30,000.00 ",4/17/2015,2015
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$50,000.00 ",4/18/2011,2011
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$40,000.00 ",4/18/2012,2012
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$10,000.00 ",4/21/2008,2008
DE,US Strategies,ADVOSERV,FIRST QUARTER REPORT,"$10,000.00 ",4/30/2010,2010
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$30,000.00 ",6/29/2015,2015
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$10,000.00 ",7/3/2013,2013
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$30,000.00 ",7/10/2014,2014
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$40,000.00 ",7/15/2011,2011
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$30,000.00 ",7/15/2016,2016
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$10,000.00 ",7/16/2009,2009
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$10,000.00 ",7/17/2008,2008
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$40,000.00 ",7/17/2012,2012
DE,US Strategies,ADVOSERV,SECOND QUARTER REPORT,"$10,000.00 ",7/19/2010,2010
DE,US Strategies,ADVOSERV,MID-YEAR REPORT,"$40,000.00 ",8/6/2007,2007
DE,US Strategies,ADVOSERV,MID-YEAR REPORT,"$60,000.00 ",8/9/2006,2006
DE,US Strategies,ADVOSERV,MID-YEAR REPORT,,8/14/2000,2000
DE,US Strategies,ADVOSERV,MID-YEAR REPORT,,8/14/2001,2001
DE,US Strategies,ADVOSERV,MID-YEAR REPORT,,8/16/2004,2004
DE,US Strategies,ADVOSERV,MID-YEAR REPORT,,8/21/2002,2002
DE,US Strategies,ADVOSERV,MID-YEAR REPORT,,8/27/1999,1999
DE,US Strategies,ADVOSERV,MID-YEAR REPORT,,9/9/2005,2005
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$30,000.00 ",9/30/2016,2016
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$30,000.00 ",10/3/2014,2014
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$30,000.00 ",10/7/2015,2015
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$10,000.00 ",10/16/2009,2009
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$40,000.00 ",10/16/2012,2012
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$60,000.00 ",10/18/2010,2010
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$10,000.00 ",10/18/2013,2013
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$40,000.00 ",10/19/2011,2011
DE,US Strategies,ADVOSERV,THIRD QUARTER REPORT,"$10,000.00 ",10/20/2008,2008
DE,US Strategies,ADVOSERV,YEAR-END REPORT,,12/19/2005,2005
DE,US Strategies,ADVOSERV,FOURTH QUARTER REPORT,"$30,000.00 ",12/30/2015,2015
DE,Van Scoyoc Associates,E I DU PONT DE NEMOURS & COMPANY (DUPONT),MID-YEAR REPORT,"$60,000.00 ",8/14/2002,2002
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FOURTH QUARTER REPORT,"$50,000.00 ",1/18/2017,2016
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FOURTH QUARTER REPORT,"$30,000.00 ",1/19/2015,2014
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FOURTH QUARTER REPORT,"$50,000.00 ",1/19/2018,2017
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FOURTH QUARTER REPORT,"$30,000.00 ",1/20/2016,2015
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FOURTH QUARTER REPORT,"$50,000.00 ",1/22/2019,2018
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,REGISTRATION,,4/10/2014,2014
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$30,000.00 ",4/15/2014,2014
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$30,000.00 ",4/17/2015,2015
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$50,000.00 ",4/19/2018,2018
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$50,000.00 ",4/20/2016,2016
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$50,000.00 ",4/21/2017,2017
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,FIRST QUARTER REPORT,"$50,000.00 ",4/22/2019,2019
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$50,000.00 ",7/19/2016,2016
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$30,000.00 ",7/20/2015,2015
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$50,000.00 ",7/20/2017,2017
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$50,000.00 ",7/20/2018,2018
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$30,000.00 ",7/21/2014,2014
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,SECOND QUARTER REPORT,"$50,000.00 ",7/22/2019,2019
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$50,000.00 ",10/16/2018,2018
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$30,000.00 ",10/20/2014,2014
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$30,000.00 ",10/20/2015,2015
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$50,000.00 ",10/20/2016,2016
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$50,000.00 ",10/20/2017,2017
DE,"W Strategies, LLC",AstraZeneca Pharmaceuticals LP,THIRD QUARTER REPORT,"$50,000.00 ",10/21/2019,2019
DE,W.L. Gore & Associates,W.L. Gore & Associates,FOURTH QUARTER REPORT,"$90,000.00 ",1/16/2019,2018
DE,W.L. Gore & Associates,W.L. Gore & Associates,FOURTH QUARTER REPORT,"$150,000.00 ",1/17/2020,2019
DE,W.L. Gore & Associates,W.L. Gore & Associates,FOURTH QUARTER REPORT,"$70,000.00 ",1/18/2018,2017
DE,W.L. Gore & Associates,W.L. Gore & Associates,FIRST QUARTER REPORT,"$120,000.00 ",4/19/2019,2019
DE,W.L. Gore & Associates,W.L. Gore & Associates,SECOND QUARTER REPORT,"$140,000.00 ",7/16/2018,2018
DE,W.L. Gore & Associates,W.L. Gore & Associates,SECOND QUARTER REPORT,"$90,000.00 ",7/18/2017,2017
DE,W.L. Gore & Associates,W.L. Gore & Associates,SECOND QUARTER REPORT,"$170,000.00 ",7/19/2019,2019
DE,W.L. Gore & Associates,W.L. Gore & Associates,REGISTRATION,,8/21/2015,2015
DE,W.L. Gore & Associates,W.L. Gore & Associates,THIRD QUARTER REPORT,"$120,000.00 ",10/17/2019,2019
DE,W.L. Gore & Associates,W.L. Gore & Associates,THIRD QUARTER REPORT,"$60,000.00 ",10/18/2018,2018
DE,W.L. Gore & Associates,W.L. Gore & Associates,THIRD QUARTER REPORT,"$70,000.00 ",10/20/2017,2017
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$50,000.00 ",1/12/2016,2015
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$50,000.00 ",1/12/2017,2016
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$50,000.00 ",1/15/2015,2014
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$80,000.00 ",1/16/2014,2013
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$50,000.00 ",1/18/2013,2012
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$50,000.00 ",1/20/2010,2009
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$50,000.00 ",1/20/2011,2010
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$50,000.00 ",1/20/2012,2011
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FOURTH QUARTER REPORT,"$60,000.00 ",1/21/2009,2008
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),YEAR-END REPORT,"$100,000.00 ",2/12/2007,2006
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),YEAR-END REPORT,"$100,000.00 ",2/13/2008,2007
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),YEAR-END REPORT,"$40,000.00 ",2/14/2001,2000
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),YEAR-END REPORT,"$40,000.00 ",2/14/2002,2001
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),YEAR-END REPORT,"$40,000.00 ",2/14/2003,2002
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),YEAR-END REPORT,"$100,000.00 ",2/14/2005,2004
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),YEAR-END REPORT,"$40,000.00 ",2/17/2004,2003
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$50,000.00 ",4/14/2015,2015
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$50,000.00 ",4/14/2016,2016
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER AMENDMENT,"$50,000.00 ",4/15/2016,2016
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$80,000.00 ",4/17/2014,2014
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$100,000.00 ",4/20/2009,2009
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$50,000.00 ",4/20/2010,2010
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$50,000.00 ",4/20/2011,2011
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$50,000.00 ",4/20/2012,2012
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$50,000.00 ",4/21/2008,2008
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),FIRST QUARTER REPORT,"$80,000.00 ",4/22/2013,2013
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$50,000.00 ",7/12/2016,2016
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$50,000.00 ",7/15/2010,2010
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$50,000.00 ",7/16/2015,2015
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$60,000.00 ",7/17/2008,2008
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER AMENDMENT,"$80,000.00 ",7/18/2014,2014
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$80,000.00 ",7/18/2014,2014
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$50,000.00 ",7/19/2012,2012
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$80,000.00 ",7/19/2013,2013
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$50,000.00 ",7/20/2009,2009
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),SECOND QUARTER REPORT,"$50,000.00 ",7/20/2011,2011
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),MID-YEAR REPORT,"$20,000.00 ",8/14/2000,2000
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),MID-YEAR REPORT,"$40,000.00 ",8/14/2001,2001
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),MID-YEAR REPORT,"$40,000.00 ",8/14/2002,2002
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),MID-YEAR REPORT,"$80,000.00 ",8/14/2003,2003
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),MID-YEAR REPORT,"$100,000.00 ",8/14/2006,2006
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),MID-YEAR REPORT,"$100,000.00 ",8/14/2007,2007
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),MID-YEAR REPORT,,8/16/1999,1999
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),MID-YEAR REPORT,"$60,000.00 ",8/16/2004,2004
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$50,000.00 ",10/12/2016,2016
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$50,000.00 ",10/16/2015,2015
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$50,000.00 ",10/17/2014,2014
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$80,000.00 ",10/18/2013,2013
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$50,000.00 ",10/19/2012,2012
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$50,000.00 ",10/20/2008,2008
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$50,000.00 ",10/20/2009,2009
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$50,000.00 ",10/20/2010,2010
DE,"Williams and Jensen, PLLC",ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP),THIRD QUARTER REPORT,"$50,000.00 ",10/20/2011,2011
DE,WINNING STRATEGIES WASHINGTON,Nanticoke Memorial Hospital,FOURTH QUARTER REPORT,"$20,000.00 ",1/18/2018,2017
DE,WINNING STRATEGIES WASHINGTON,Nanticoke Memorial Hospital,SECOND QUARTER REPORT,"$20,000.00 ",7/18/2017,2017
DE,WINNING STRATEGIES WASHINGTON,Nanticoke Memorial Hospital,THIRD QUARTER REPORT,"$20,000.00 ",10/16/2017,2017
